The age of viability is the earliest point in pregnancy at which a baby has a realistic chance of surviving outside the womb, generally considered to be around 24 weeks of gestation. Before that threshold, survival rates fall below 50 percent. However, advances in neonatal care have blurred this line, and some infants born as early as 22 weeks now survive with aggressive medical intervention.
Why 24 Weeks Is the Standard Threshold
The age of viability centers on 24 weeks because of a biological milestone: this is the stage when a fetus’s lungs develop enough basic structure to potentially exchange oxygen, though they’re still extremely immature. Without functional lungs, no amount of technology can sustain life outside the uterus. At 24 weeks, about 71 percent of infants who receive active life support in a neonatal intensive care unit (NICU) survive to go home from the hospital. By 25 weeks, that number climbs to 82 percent.
The threshold isn’t a hard cutoff. It sits within a gray zone, sometimes called the “periviable” period, spanning roughly 22 to 24 weeks. Within this window, every additional day of development meaningfully shifts the odds.
Survival Rates Week by Week
Data from the American Academy of Pediatrics, covering infants born between 2020 and 2022 who received active life support, shows how dramatically survival changes across just a few weeks:
- 22 weeks: about 36 percent survive
- 23 weeks: about 55 percent survive
- 24 weeks: about 72 percent survive
- 25 weeks: about 82 percent survive
These numbers apply to infants who received full resuscitation and NICU care. When you include all births at a given gestational age, including those where comfort care was chosen instead of aggressive intervention, the overall survival rate at 22 weeks drops to roughly 25 percent. The gap between those two numbers reflects a reality explored more below: at the earliest gestational ages, whether active treatment is attempted is itself a major variable.
Factors Beyond Gestational Age
Weeks of gestation get the most attention, but several other factors shift a baby’s odds by an amount roughly equivalent to an extra week of development. These include:
- Birth weight: Heavier babies at the same gestational age tend to fare better. Even small differences of 100 to 200 grams matter at this stage.
- Biological sex: Female infants have consistently higher survival rates than males at the same gestational age. Their lungs tend to mature slightly faster.
- Singleton vs. multiple pregnancy: A baby from a single pregnancy has better odds than one from twins or triplets born at the same point.
- Steroid injections before birth: When doctors have enough warning that a very early delivery is likely, they can give the mother steroid injections that accelerate the baby’s lung development. This single intervention significantly reduces the risk of death and disability.
Because of these variables, two babies born at the same gestational age can face very different outlooks. A 23-week female singleton whose mother received steroids may have survival odds more comparable to a 24-week infant without those advantages.
What Happens in the NICU
Babies born at the edge of viability almost always need mechanical breathing support, and many depend on it for weeks or months. Their lungs lack a substance that keeps air sacs from collapsing, so they typically receive a replacement through a breathing tube. Some start on a ventilator and transition to gentler forms of breathing support as they grow stronger. Others cycle between the two for extended periods.
Beyond breathing, these infants face challenges with temperature regulation, feeding, infection, and brain bleeds. A baby born at 23 or 24 weeks may spend three to four months in the NICU before going home, often not leaving until close to what would have been their original due date.
Long-Term Health After Periviable Birth
Survival is only part of the picture. Among infants who survive birth at 22 weeks, about 60 percent have moderate to severe developmental impairments. At 23 weeks, that rate is around 50 percent. At 24 weeks, it’s roughly 42 percent, and at 25 weeks, about 23 percent. These impairments can include cerebral palsy, significant learning disabilities, vision or hearing loss, and challenges with motor skills.
Follow-up studies of children assessed between ages 4 and 10 show a similar pattern, with disability rates of around 42 percent for those born at 22 weeks, gradually declining to 23 percent at 25 weeks. Some children born this early develop normally or with only mild delays, but the probability of significant challenges remains high at the lowest gestational ages.
The Decision Families Face
At 22 or 23 weeks, families are often asked to participate in one of the hardest decisions in medicine: whether to pursue full resuscitation and NICU care, or to focus on comfort care, keeping the baby warm and pain-free without aggressive intervention. There is no single right answer, and guidelines from the American College of Obstetricians and Gynecologists emphasize that this should be a shared decision informed by balanced, unbiased information.
A multidisciplinary team, typically including obstetricians, neonatologists, social workers, and sometimes ethicists or chaplains, walks families through the likely outcomes. They discuss not just survival odds but what the path to survival looks like: months of intensive care, potential surgeries, and the range of long-term outcomes. These conversations happen in the context of evolving information, since a baby’s condition at birth may look different from what was predicted hours earlier, and recommendations can shift as new details emerge.
By 25 or 26 weeks, the question is different. Survival is likely enough that active resuscitation is standard practice, and the focus shifts to optimizing care rather than deciding whether to intervene.
How the Age of Viability Has Shifted
Three decades ago, 24 weeks was considered the firm floor of viability, and outcomes even at that age were poor. Over the past 25 years, improvements in prenatal steroid use, gentler ventilation techniques, and better infection control have pushed survival earlier. The most notable shift has been at 22 and 23 weeks, where active resuscitation was rarely attempted before the early 2000s. As more hospitals began offering intervention at these ages, mortality data initially appeared to worsen, simply because more extremely premature infants were being counted in the statistics. Over time, survival rates at these ages have genuinely improved as care protocols matured.
The biological limits of viability, rooted in lung and brain development, mean this threshold is unlikely to shift dramatically further. But incremental gains continue, and hospitals with specialized periviable programs tend to report meaningfully better outcomes than those without dedicated expertise at these gestational ages.